| http://www.w3.org/ns/prov#value | - response to treatment information of all reported cases of levamisole-induced cutaneous vasculitisLevamisole was an FDA-approved drug but was withdrawn for use in humans in the USA in 1999 due to reports of serious adverse effects such as agranulocytosis, thrombocytopenia, arthritis, and LIV
|
